Preferred Label : Metformin Hydrochloride;
NCIt synonyms : Metformin HCl; 1,1-Dimethylbiguanide Hydrochloride; N,N-Dimethylimidodicarbonimidic Diamide Monohydrochloride; Cidophage; APO-Metformin;
NCIt related terms : Glucophage;
NCIt definition : The hydrochloride salt of the biguanide metformin with antihyperglycemic and potential
antineoplastic activities. Metformin inhibits complex I (NADPH:ubiquinone oxidoreductase)
of the mitochondrial respiratory chain, thereby increasing the cellular AMP to ATP
ratio and leading to activation of AMP-activated protein kinase (AMPK) and regulating
AMPK-mediated transcription of target genes. This eventually prevents hepatic gluconeogenesis,
enhances insulin sensitivity and fatty acid oxidation and ultimately leads to a decrease
in glucose levels. Metformin may exert antineoplastic effects through AMPK-mediated
or AMPK-independent inhibition of mammalian target of rapamycin (mTOR), which is up-regulated
in many cancer tissues. Furthermore, this agent also inhibits tumor cell migration
and invasion by inhibiting matrix metalloproteinase-9 (MMP-9) expression which is
mediated through the suppression of transcription activator protein-1 (AP-1) activation.;
Alternative definition : NCI-GLOSS: A drug used to treat diabetes mellitus (a condition in which the body cannot
control the level of sugar in the blood). It is also being studied in the treatment
of cancer. It decreases the amount of glucose (a type of sugar) released into the
bloodstream from the liver and increases the body's use of the glucose. Glucophage
is a type of antidiabetic agent.;
UNII : 786Z46389E;
InChIKey : OETHQSJEHLVLGH-UHFFFAOYSA-N;
CAS number : 1115-70-4;
Drug name : Glucophage; Glucoformin; Glifage; Glucophage ER; Dimefor; Siofor; Riomet;
Chemical formula : C4H11N5.HCl;
NSC code : 91485;
Codes from synonyms : CDR0000631045; CDR0000631046; 09726;
Origin ID : C29251;
UMLS CUI : C0770893;
Currated CISMeF NLP mapping
See also inter- (CISMeF)
Semantic type(s)
Validated automatic mappings to NTBT
concept_is_in_subset
has_free_acid_or_base_form
has_target
is_salt_form_of
https://www.has-sante.fr/jcms/p_3283449/fr/komboglyze-metformine-/-saxagliptine
2021
false
false
false
France
evaluation of the transparency committee
saxagliptin
metformin
dipeptides
adamantane
metformin and saxagliptin
treatment outcome
insurance, health, reimbursement
drug combinations
Saxagliptin Hydrochloride
Metformin Hydrochloride
diabetes mellitus, type 2
hypoglycemic agents
drug therapy, combination
administration, oral
adult
incretins
dipeptidyl-peptidase iv inhibitors
---
http://www.has-sante.fr/portail/jcms/c_1782549/fr/komboglyze
http://www.has-sante.fr/portail/jcms/c_1782549/fr/komboglyze-saxagliptine/metformine-antidiabetique
2014
false
France
French
sulfonylurea compounds
Metformin Hydrochloride
Saxagliptin Hydrochloride
guidelines for drug use
evaluation of the transparency committee
drug combinations
saxagliptin
saxagliptin
metformin and saxagliptin
administration, oral
insurance, health, reimbursement
metformin
metformin
hypoglycemic agents
hypoglycemic agents
adult
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
adamantane
dipeptides
aged
drug therapy, combination
dipeptides
dipeptides
---